Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis ; volume:24 ; number:1 ; day:18 ; month:11 ; year:2024 ; pages:1-11 ; date:12.2024
BMC endocrine disorders ; 24, Heft 1 (18.11.2024), 1-11, 12.2024
- Creator
-
Shabil, Muhammed
Khatib, Mahalaqua Nazli
Ballal, Suhas
Bansal, Pooja
Tomar, Balvir S.
Ashraf, Ayash
Kumar, M. Ravi
Sinha, Aashna
Rawat, Pramod
Gaidhane, Abhay M.
Sah, Sanjit
Daniel, Afukonyo Shidoiku
Yappalparvi, Ambanna
Bushi, Ganesh
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12902-024-01775-2
- URN
-
urn:nbn:de:101:1-2502042059508.024949646596
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shabil, Muhammed
- Khatib, Mahalaqua Nazli
- Ballal, Suhas
- Bansal, Pooja
- Tomar, Balvir S.
- Ashraf, Ayash
- Kumar, M. Ravi
- Sinha, Aashna
- Rawat, Pramod
- Gaidhane, Abhay M.
- Sah, Sanjit
- Daniel, Afukonyo Shidoiku
- Yappalparvi, Ambanna
- Bushi, Ganesh
- SpringerLink (Online service)
Other Objects (12)
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia
The insulinotropic gut hormone glucagon-like peptide-1 : 20 tables
Untersuchungen zur Struktur-Wirkungsbeziehung des Inkretinhormons Glucagon-like Peptide-1
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia
The insulinotropic gut hormone glucagon-like peptide-1 : 20 tables
Untersuchungen zur Struktur-Wirkungsbeziehung des Inkretinhormons Glucagon-like Peptide-1
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia
The insulinotropic gut hormone glucagon-like peptide-1 : 20 tables